- Home
- PSFE vs PALI Comparison
PSFE vs PALI Comparison
Compare PSFE & PALI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PSFE | PALI |
|---|---|---|
| Founded | 1996 | 1996 |
| Country | United Kingdom | United States |
| Employees | 2900 | N/A |
| Industry | Business Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 347.5M | 359.7M |
| IPO Year | N/A | 2019 |
Fundamental Metrics
Financial Performance| Metric | PSFE | PALI |
|---|---|---|
| Price | $7.85 | $1.96 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 4 | 7 |
| Target Price | $8.69 | ★ $11.29 |
| AVG Volume (30 Days) | 206.0K | ★ 2.8M |
| Earning Date | 05-13-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 97.06 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $260,000.00 |
| Revenue This Year | $8.15 | N/A |
| Revenue Next Year | $6.25 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 1500.39 |
| 52 Week Low | $5.95 | $0.55 |
| 52 Week High | $15.02 | $2.86 |
Technical Indicators
Market Signals| Indicator | PSFE | PALI |
|---|---|---|
| Relative Strength Index (RSI) | 48.20 | 50.11 |
| Support Level | $7.68 | $1.57 |
| Resistance Level | $8.50 | $1.96 |
| Average True Range (ATR) | 0.41 | 0.12 |
| MACD | -0.03 | -0.01 |
| Stochastic Oscillator | 20.67 | 31.94 |
Price Performance
Historical ComparisonAbout PSFE Paysafe Limited
Paysafe Ltd is an integrated payments platform. Its core purpose is to enable businesses and consumers to connect and transact seamlessly through capabilities in payment processing, digital wallet, and online cash solutions. The company's reportable segments are Merchant Solutions and Digital Wallets. The Merchant Solutions segment, which derives maximum revenue, services markets in North America, Canada and Europe. The Digital Wallets segment services markets in Europe, UK, North America and Latin America. It derives a majority of revenue from the USA followed by Germany, the UK, and all other countries.
About PALI Palisade Bio Inc.
Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.